LABORATORY NEWS
-
Cancer Is Striking Earlier - Superpower And GRAIL Are Partnering To Expand Early Detection
Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (Nasdaq: GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test.
- Breaking The PCR-Only Barrier: Dual 510(k) Clearance And CLIA-Waiver Establish FINDER As The First Molecular Point-Of-Care Platform With Multifunctional Capabilities
- Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM
- LabConnect Launches SampleGISTICS® 2.0 To Digitize Clinical Trial Sample Capture
- Takara Bio USA And Hamilton Company Partner To Automate NGS Library Preparation
ARCHIVED NEWSLETTER
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- 01.20.26 -- Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
- 01.06.26 -- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- 12.23.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?